BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11736862)

  • 1. Human thiopurine methyltransferase activity varies with red blood cell age.
    Lennard L; Chew TS; Lilleyman JS
    Br J Clin Pharmacol; 2001 Nov; 52(5):539-46. PubMed ID: 11736862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Physiology-Based Mathematical Model to Estimate Red Blood Cell Lifespan in Different Human Age Groups.
    An G; Widness JA; Mock DM; Veng-Pedersen P
    AAPS J; 2016 Sep; 18(5):1182-1191. PubMed ID: 27215601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Models for the red blood cell lifespan.
    Shrestha RP; Horowitz J; Hollot CV; Germain MJ; Widness JA; Mock DM; Veng-Pedersen P; Chait Y
    J Pharmacokinet Pharmacodyn; 2016 Jun; 43(3):259-74. PubMed ID: 27039311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Thiopurine S-Methyltransferase (TPMT) Activity in Human Erythrocytes by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Li L; Atkinson N; Crews KR; Molinelli AR
    Methods Mol Biol; 2024; 2737():465-472. PubMed ID: 38036847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulators: still having a role?
    Venner JM; Bernstein CN
    Gastroenterol Rep (Oxf); 2022; 10():goac061. PubMed ID: 36381225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS Method for Measurement of Thiopurine Nucleotides (TN) in Erythrocytes and Association of TN Concentrations With TPMT Enzyme Activity.
    Bajaj AO; Kushnir MM; Kish-Trier E; Law RN; Zuromski LM; Molinelli AR; McMillin GA; Johnson-Davis KL
    Front Pharmacol; 2022; 13():836812. PubMed ID: 35387339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
    Nielsen SN; Toksvang LN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Appell ML; Hjalgrim LL; Schmiegelow K
    Cancer Chemother Pharmacol; 2021 Aug; 88(2):271-279. PubMed ID: 33928426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of thiopurines in inflammatory bowel disease: an update.
    Singh A; Mahajan R; Kedia S; Dutta AK; Anand A; Bernstein CN; Desai D; Pai CG; Makharia G; Tevethia HV; Mak JW; Kaur K; Peddi K; Ranjan MK; Arkkila P; Kochhar R; Banerjee R; Sinha SK; Ng SC; Hanauer S; Verma S; Dutta U; Midha V; Mehta V; Ahuja V; Sood A
    Intest Res; 2022 Jan; 20(1):11-30. PubMed ID: 33845546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Identification of a Novel Thiopurine S-Methyltransferase Allele,
    Ha C; Kim ES; Kwon Y; Choe YH; Kim MJ; Lee SY
    Pharmgenomics Pers Med; 2020; 13():665-671. PubMed ID: 33273844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic studies of thiopurine methyltransferase genotype-phenotype concordance and effect of methotrexate on thiopurine metabolism.
    Zimdahl Kahlin A; Helander S; Wennerstrand P; Vikingsson S; Mårtensson LG; Appell ML
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):52-65. PubMed ID: 32865889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers Predictive of Response to Thiopurine Therapy in Inflammatory Bowel Disease.
    Cornish JS; Wirthgen E; Däbritz J
    Front Med (Lausanne); 2020; 7():8. PubMed ID: 32064265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical guide to thiopurine prescribing and monitoring in IBD.
    Warner B; Johnston E; Arenas-Hernandez M; Marinaki A; Irving P; Sanderson J
    Frontline Gastroenterol; 2018 Jan; 9(1):10-15. PubMed ID: 29484155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned.
    Weitzel KW; Smith DM; Elsey AR; Duong BQ; Burkley B; Clare-Salzler M; Gong Y; Higgins TA; Kong B; Langaee T; McDonough CW; Staley BJ; Vo TT; Wake DT; Cavallari LH; Johnson JA
    Clin Transl Sci; 2018 Mar; 11(2):175-181. PubMed ID: 29351371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurine S-Methyltransferase as a Pharmacogenetic Biomarker: Significance of Testing and Review of Major Methods.
    Asadov C; Aliyeva G; Mustafayeva K
    Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):23-30. PubMed ID: 28552060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response.
    Abaji R; Krajinovic M
    Pharmgenomics Pers Med; 2017; 10():143-156. PubMed ID: 28507448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.
    Tamm R; Mägi R; Tremmel R; Winter S; Mihailov E; Smid A; Möricke A; Klein K; Schrappe M; Stanulla M; Houlston R; Weinshilboum R; Mlinarič Raščan I; Metspalu A; Milani L; Schwab M; Schaeffeler E
    Clin Pharmacol Ther; 2017 May; 101(5):684-695. PubMed ID: 27770449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.
    Liu C; Yang W; Pei D; Cheng C; Smith C; Landier W; Hageman L; Chen Y; Yang JJ; Crews KR; Kornegay N; Karol SE; Wong FL; Jeha S; Sandlund JT; Ribeiro RC; Rubnitz JE; Metzger ML; Pui CH; Evans WE; Bhatia S; Relling MV
    Clin Pharmacol Ther; 2017 Mar; 101(3):373-381. PubMed ID: 27564568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.
    Schmiegelow K; Nielsen SN; Frandsen TL; Nersting J
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):503-17. PubMed ID: 24936744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of TPMT testing.
    Lennard L
    Br J Clin Pharmacol; 2014 Apr; 77(4):704-14. PubMed ID: 23962279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate binds to recombinant thiopurine S-methyltransferase and inhibits enzyme activity after high-dose infusions in childhood leukaemia.
    Wennerstrand P; Mårtensson LG; Söderhäll S; Zimdahl A; Appell ML
    Eur J Clin Pharmacol; 2013 Sep; 69(9):1641-9. PubMed ID: 23660772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.